Diabetes eye complications are the leading cause of blindness in US adults aged 25-74. After 60+ years of debate as to the role of hyperglycemia in diabetes complications development, clinical trials demonstrated that reducing hyperglycemic exposure enormously reduces complication rate (Diabetes Control and Complications Trial (DCCT)). However, good blood glucose control does not eliminate retinopathic complications. This necessarily focuses diabetes research on development of additional treatments aimed not at diabetes control, but at prevention/treatment of specific complications. Laboratory research into the mechanisms of hyperglycemic damage and for development of new treatments to arrest these processes will be successful and clinical trials are an essential step in implementation of any new treatments. Clinical trials rely on prior identification of 1) at risk populations/tissues and 2) sensitive methods to monitor treatment effects. Our long-term research goal is to establish functional indicators of diabetic eye health and predictors of vision loss, and thus help in the prevention and treatment of the retinal complications of diabetes. Earlier we identified vision function changes that precede the development of retinopathy. In the current application period we showed that local ERGs show local changes corresponding to the local areas of visible diabetic retinopathic signs. Local correspondence of functional defects and local retinal damage hadn't been established using clinical visual field measures. Local areas of functional ERG loss are also evident in eyes without retinopathy. The research in the application proposes prediction of specific areas of future irreversible retinal damage based on local ERGs. We recently showed direct effects of acute glycemic levels on human vision function. We've shown that the FEOG is very sensitive to blood glucose fluctuations in both non-diabetics and diabetics. And, the diabetic FEOG appears to differ from that of the non-diabetic. The FEOG, a non-invasive objective measure of the eye's electrical response to light at the RPE/photoreceptor interface, reflects chloride transport by the retinal pigment epithelium. We will test the hypothesis that alterations in FEOG measures of RPE function precede retinopathy, and further, that FEOG measures in those with retinopathy and those with poor glycemic control differ from those of diabetics without retinopathy and with good control, respectively.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY002271-20
Application #
6518288
Study Section
Special Emphasis Panel (ZRG1-VISC (03))
Program Officer
Dudley, Peter A
Project Start
1978-01-01
Project End
2005-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
20
Fiscal Year
2002
Total Cost
$299,756
Indirect Cost
Name
University of California Berkeley
Department
Type
Schools of Optometry/Ophthalmol
DUNS #
094878337
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Ozawa, Glen Y; Bearse Jr, Marcus A; Adams, Anthony J (2015) Male-female differences in diabetic retinopathy? Curr Eye Res 40:234-46
Wolff, B E; Bearse Jr, M A; Schneck, M E et al. (2015) Color vision and neuroretinal function in diabetes. Doc Ophthalmol 130:131-9
Dhamdhere, Kavita P; Schneck, Marilyn E; Bearse Jr, Marcus A et al. (2014) Assessment of macular function using the SKILL Card in adults with type 2 diabetes mellitus. Invest Ophthalmol Vis Sci 55:3368-74
Ozawa, Glen Y; Bearse Jr, Marcus A; Harrison, Wendy W et al. (2014) Differences in neuroretinal function between adult males and females. Optom Vis Sci 91:602-7
Adams, Anthony J; Bearse Jr, Marcus A (2012) Retinal neuropathy precedes vasculopathy in diabetes: a function-based opportunity for early treatment intervention? Clin Exp Optom 95:256-65
Tam, Johnny; Dhamdhere, Kavita P; Tiruveedhula, Pavan et al. (2012) Subclinical capillary changes in non-proliferative diabetic retinopathy. Optom Vis Sci 89:E692-703
Ozawa, Glen Y; Bearse Jr, Marcus A; Bronson-Castain, Kevin W et al. (2012) Neurodegenerative differences in the retinas of male and female patients with type 2 diabetes. Invest Ophthalmol Vis Sci 53:3040-6
Harrison, Wendy W; Chang, Ann; Cardenas, Maria G et al. (2012) Blood pressure, vessel caliber, and retinal thickness in diabetes. Optom Vis Sci 89:1715-20
Laron, Michal; Bearse Jr, Marcus A; Bronson-Castain, Kevin et al. (2012) Association between local neuroretinal function and control of adolescent type 1 diabetes. Invest Ophthalmol Vis Sci 53:7071-6
Laron, Michal; Bearse Jr, Marcus A; Bronson-Castain, Kevin et al. (2012) Interocular symmetry of abnormal multifocal electroretinograms in adolescents with diabetes and no retinopathy. Invest Ophthalmol Vis Sci 53:316-21

Showing the most recent 10 out of 59 publications